» Articles » PMID: 12073058

Polypoidal Choroidal Vasculopathy with Large Vascular Network

Overview
Specialty Ophthalmology
Date 2002 Jun 20
PMID 12073058
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report characteristics of polypoidal choroidal vasculopathy (PCV) of large vascular networks that expand across the retinal vascular arcade.

Methods: Among 60 consecutive eyes diagnosed as having PCV by fluorescein and indocyanine green (ICG) angiography, 12 eyes (9 patients) showed large lesions. The clinical and angiographic features of these 12 eyes were studied retrospectively.

Results: Cases of large PCV typically showed dilated network vessels, which spread radially, and multiple polypoidal dilations at the end of the network vessels. Most of the polypoidal dilations formed clusters resembling bunches of grapes and caused large serous and/or hemorrhagic pigment epithelial detachments (PEDs). Among the 12 eyes, 5 showed rapid expansion of the lesions and became large PCVs within 3-24 months. In these eyes, ICG angiography revealed mesh-like choroidal vessels beneath the retinal pigment epithelium.

Conclusion: PCV with a large vascular network that expands across the vascular arcade is not uncommon. Some of these cases seems to have characteristics of choroidal neovascularization rather than choroidal vasculopathy. It is not easy to distinguish such cases from exudative age-related macular degeneration even though they showed typical findings of PCV on ICG angiography.

Citing Articles

Novel Findings of Polypoidal Choroidal Vasculopathy via Optical Coherence Tomography Angiography.

Seong S, Choo H, Kim Y, Kim J, Lee J, Oh H Korean J Ophthalmol. 2019; 33(1):54-62.

PMID: 30746912 PMC: 6372389. DOI: 10.3341/kjo.2018.0048.


Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of 'expanded spectra' - a review.

Dansingani K, Gal-Or O, Sadda S, Yannuzzi L, Freund K Clin Exp Ophthalmol. 2017; 46(2):189-200.

PMID: 29178419 PMC: 5900982. DOI: 10.1111/ceo.13114.


Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy.

Kong M, Kim S, Ham D PLoS One. 2017; 12(9):e0184058.

PMID: 28886052 PMC: 5590886. DOI: 10.1371/journal.pone.0184058.


Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters.

Lee J, Lee W Graefes Arch Clin Exp Ophthalmol. 2015; 254(4):645-51.

PMID: 26138657 DOI: 10.1007/s00417-015-3092-1.


Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatment.

Chae J, Lee J, Yang S, Kim J, Yoon Y Korean J Ophthalmol. 2011; 25(2):98-104.

PMID: 21461221 PMC: 3060400. DOI: 10.3341/kjo.2011.25.2.98.